Lanzatech co-founder: we are missing out on the synthetic biology revolution

Lanzatech co-founder: we are missing out on the synthetic biology revolution
Dr Sean Simpson. (Image: Getty)
Peter Griffin
The third New Zealand-founded company in as many years is set to list on the Nasdaq.LanzaTech’s merger with “blank cheque” Nasdaq-listed company AMCI Acquisition Corp II sees it follow in the footsteps of Rocket Lab and footwear maker All Birds in taking the special purpose acquisition company (SPAC) route to become a publicly traded company.The deal, which values the merged company at around US$1.8 billion (NZ$2.8b), was cleared by shareholders on Tuesday. It confirms the Illinois-based LanzaTech’s status as our mo...

More Opinion

You won’t trust AI if you don’t understand it
Opinion

Peter Griffin: You won’t trust AI if you don’t understand it

The goal for AI should be to develop “critical use" because it has many flaws.

Peter Griffin 07 May 2025
Organic traffic is softening thanks to AI
Opinion

Ben Goodale: Organic traffic is softening thanks to AI

AI still can’t replicate experience. And that’s where brands need to double down.

Ben Goodale 06 May 2025
Why folks worry about the end of Buffett country
Opinion

David Chaplin: Why folks worry about the end of Buffett country

If there were a Pope of capitalism, Buffett would be the only candidate.

David Chaplin 06 May 2025